810223P
Avanti
C12-NBD Glucosyl Ceramide
Avanti Polar Lipids
Sign Into View Organizational & Contract Pricing
All Photos(1)
N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-β1-1′-sphingosine
C42H71N5O11
Recommended Products
Assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 1 mg (810223P-1MG)
pkg of 1 × 250 μg (810223P-250ug)
manufacturer/tradename
Avanti Polar Lipids
shipped in
dry ice
storage temp.
−20°C
Application
C12-NBD Glucosyl Ceramide is suitable for liposome preparation.
Biochem/physiol Actions
Glucosyl ceramide (GlcCer) is produced by GlcCer synthase from ceramide in the cytosolic membranes of Golgi. In the luminal Golgi membrane, GlcCer participates in the generation of glycosphingolipids.
Packaging
5 mL Amber Glass Screw Cap Vial (810223P-1MG)
5 mL Amber Glass Screw Cap Vial (810223P-250ug)
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Information
新产品
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
The effects of chemically synthesized saposin C on glucosylceramide-beta-glucosidase
Clinical Biochemistry, 48(16-17), 1177-1180 (2015)
Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide
Nature, 449(7158), 62-62 (2007)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service